📰 Genentech News
Page 86 - Genentech News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Genentech. Real-time updates on events, politics, business and more.
October 25, 2023
/PRNewswire/ -- PatientPoint® today announced exciting growth within its client strategy, analytics and sales organizations, further strengthening its...
October 25, 2023
/PRNewswire/ -- DelveInsights High-grade Glioma Market Insights report includes a comprehensive understanding of current treatment practices, high-grade...
October 24, 2023
By AKANI CHAUKE JOHANNESBURG, (CAJ News) - THE multinational healthcare company, Roche, and the Africa Research Excellence Fund (AREF) have teamed up to support the next generation of scientists from the continent. The AREF-Roche and Genentech Fellowship Programme will support three emerging African scientists to become leaders in the fields of clinical pharmacology, pathology and
October 24, 2023
October 29th marks the 41st anniversary of one of biotechnology’s most significant milestones — the approval by the Food and Drug Administration of Humulin, human insulin synthesized in genetically engineered bacteria to treat diabetes. The first “biopharmaceutical,” or drug made with molecular genetic engineering techniques, to be approved, it launched a revolutionary era in drug development.
October 24, 2023
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the entry into a definitive agreement to acquire Telavant Holdings, Inc. (Telavant), a Roivant company, owned by Roivant Sciences Ltd. and Pfizer Inc.. The agreement includes the development, manufacturing and commercialisation rights in the US and Japan for ...
October 24, 2023
Alcami Corp., a pharmaceutical contract development and manufacturing organization, has appointed Ta
October 24, 2023
The lawsuit was over an arthritis drug.
October 24, 2023
A regimen of pre-surgical immunotherapy and chemotherapy followed by post-surgical immunotherapy significantly improved event-free survival (EFS) and pathologic complete response (pCR) rates compared to chemotherapy alone for patients with operable non-small cell lung cancer (NSCLC), according to results of a Phase III trial reported by researchers at The University of Texas MD Anderson Cancer Center.
October 23, 2023
MiraCosta College generates nearly $650 million in economic impact, according to the findings of a report released last week.
October 23, 2023
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the entry into a definitive agreement to acquire Telavant Holdings, Inc. (Telavant), a Roivant company, owned by Roivant Sciences Ltd. and Pfizer Inc.. The agreement includes the development, manufacturing and commercialisation rights in the US and Japan for ...